Completed Projects

Renal Impairment at diagnosis in myeloma: an analysis of patient characteristics, treatment, and impact on outcomes

Researcher(s)

Prof Joy Ho, Clinical Professor and Senior staff specialist, Haematology, Royal Prince Alfred Hospital, Sydney

Progress

Published 2019 - Project complete

The Myeloma Landscape in Australia and New Zealand (ANZ): The first years of the Myeloma and Related Diseases Registry (MRDR)

Researcher(s)

Dr Krystal Bergin, Consultant haematologist & PhD student, The Alfred Hospital, Melbourne

Progress

Published in Clinical Lymphoma, Myeloma and Leukemia: January 29, 2021. Project complete

Rates of Upfront Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM): Comparing ASCT recipients and non-recipients

Researcher(s)

Dr Krystal Bergin, Consultant haematologist & PhD student, The Alfred Hospital, Melbourne

Progress

Published in Bone Marrow Transplantation: 19 May 2021. Project complete.

Pacific Islanders with MM in New Zealand compared to other ethnicities: characteristics, treatment and outcomes

Researcher(s)

A/Prof Hilary Blacklock, Consultant haematologist, Middlemore Hospital, Auckland, New Zealand

Progress

Presented at International Myeloma Workshop 2019, Boston, USA and Blood 2019, Perth. Published in Clinical Lymphoma, Myeloma and Leukemia: April 8th, 2022. Project complete

The Impact of Body Weight on Melphalan dosing in Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Master's thesis topic

Researcher(s)

Dervla O'Ryan, Masters Student and Clinical Pharmacist, The Alfred Hospital, Melbourne

Progress

Masters thesis sucessfully completed - Project complete

Overview of imaging modalities in multiple myeloma - used for presentation on 18F-FDG-PET/CT to support uptake of the internationally preferred imaging modality in Australia

Researcher(s)

Dr Kylee McLachlan, Consultant Haematologist, Peter MacCallum Cancer Centre, Melbourne

Progress

Oral Presentation at Blood 2018 - Project complete

Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)

Researcher(s)

A/Prof Zoe McQuilten, School of Public Health and Preventive Medicine, Monash University (Consultant haematologist)

Progress

Published in British Journal of Haematology: June 9th 2022. Project complete.

Analysis of bortezomib-based therapy in non-transplant eligible multiple myeloma

Researcher(s)

A/Prof Peter Mollee (Consultant haematologist) and Dr Stephen Boyle (Registrar), Princess Alexandra Hospital, Brisbane

Progress

Poster presentation at the International Myeloma Workshop in Boston, Sept 2019. Published in European Journal of Haematology: June 15, 2021. Project complete.

Methylation biomarkers in plasma cell free DNA in myeloma

Researcher(s)

Prof Ian Morison, Professor of Pathology, Dunedin School of Medicine, University of Otago

Progress

M1000 Biobank request - analysis complete and report sent

Treatment patterns in relapsed / refractory MM in Australia

Researcher(s)

Dr Jessie Zhao, Registrar, Dorevitch Pathology, Melbourne

Progress

Oral presentation at Blood 2019 in Perth, Australia; project complete

Comparison of patients with newly diagnosed MM who are transplant ineligible, receiving bortezomib versus lenalidomide

Researcher(s)

Natthida Khajornjiraphan, Master of Clinical Research Methods student, Monash University, and Clinical Trial Coordinator (Haematology), St Vincent's Hospital Melbourne

Progress

Analysis complete - presented at the National Myeloma Workshop 2020

Causes of death in patients with multiple myeloma

Researcher(s)

Rosalyn Cao, Master of Public Health student, Monash University

Progress

Presented at the National Myeloma Workshop 2020, Blood 2021, project complete.